- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Health Catalyst Inc (HCAT)
Assess today's live Health Catalyst Inc (HCAT) share price, performance and insights using our live NASDAQ: HCAT stock exchange data.
Analyse the historical data and Health Catalyst Inc share price performance charts on this page. Our technical summary section provides analysis on Health Catalyst share price buy/sell indicators using real-time data (or discuss the Health Catalyst (HCAT) stock price today with other investors in the Health Catalyst NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HCAT share price (ISIN: US42225T1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Health Catalyst Inc Share Price Today?
The Health Catalyst share price today is 1.45.
What Is the Stock Symbol for Health Catalyst Inc
The stock symbol (or 'ticker') for Health Catalyst Inc is "HCAT."
What Stock Exchange Does Health Catalyst Inc Trade On?
Health Catalyst Inc is listed and trades on the NASDAQ stock exchange.
Is Health Catalyst Inc a Good Stock to Buy?
Determining whether Health Catalyst Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Health Catalyst Inc share price performance charts on this page. Our technical summary section provides analysis on Health Catalyst share price buy/sell indicators using real-time data (or discuss the Health Catalyst (HCAT) stock price today with other investors in the Health Catalyst NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HCAT share price (ISIN: US42225T1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Health Catalyst Inc Share Price Today?
The Health Catalyst share price today is 1.45.
What Is the Stock Symbol for Health Catalyst Inc
The stock symbol (or 'ticker') for Health Catalyst Inc is "HCAT."
What Stock Exchange Does Health Catalyst Inc Trade On?
Health Catalyst Inc is listed and trades on the NASDAQ stock exchange.
Is Health Catalyst Inc a Good Stock to Buy?
Determining whether Health Catalyst Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.27
1.48
52 wk Range
0.96
5.06
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.271.48
52 wk Range
0.965.06
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HCAT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
1.96
Upside
+35.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 13D/A Health Catalyst For: 13 March
- Investing.com
- Health Catalyst receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Health Catalyst receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
7 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1.96
(+35.47% Upside)
Health Catalyst Inc SWOT Analysis
Platform Revolution | Explore Health Catalyst's transition to the Ignite platform, promising higher margins and enhanced flexibility in market strategy |
Market Dynamics | Delve into improving hospital margins and increased reliance on external patient engagement tools, shaping Health Catalyst's growth potential |
Financial Trajectory | Analysts project low double-digit revenue growth and 50% adjusted EBITDA growth for FY2025, with price targets ranging from $9 to $16 |
Competitive Edge | Learn how Health Catalyst's immediate ROI solutions and competitive pricing position the company in the evolving healthcare technology landscape |
Health Catalyst Inc Earnings Call Summary for Q4/2025
- Q4 revenue of $74.8M beat estimates by 1.33% but fell 6.1% YoY; EPS of $0.08 missed forecast by 20%, though stock rose 8.06% after-hours.
- Adjusted EBITDA surged 75% YoY to $13.8M; adjusted gross margin improved 690 basis points to 53.5%, reflecting operational restructuring success.
- Company withheld full-year 2026 guidance amid ongoing strategic reviews; plans focus on commercial strength, client retention, and AI capabilities.
- Platform migration challenges and market perception issues persist as key risks; competitive pressures in data infrastructure market remain concerns.
Last Updated: 12/03/2026, 22:38
Read Full TranscriptEarnings
Latest Release
12/03/2026
EPS / Forecast
0.08 / 0.10
Revenue / Forecast
74.8M / 73.82M
Compare HCAT to Peers and Sector
Metrics to compare | HCAT | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipHCATPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −0.6x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.4x | 1.5x | 2.6x | |
Price / LTM Sales | 0.3x | 0.8x | 3.2x | |
Upside (Analyst Target) | 37.9% | 67.2% | 47.8% | |
Fair Value Upside | Unlock | 25.1% | 6.7% | Unlock |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Health Catalyst (NASDAQ: HCAT) Share Price Today?
The Health Catalyst stock price today is 1.45 USD.
What Stock Exchange Does Health Catalyst (HCAT) Trade On?
Health Catalyst is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Health Catalyst?
The stock symbol (also called a 'ticker') for Health Catalyst is "HCAT."
What Is the Current Health Catalyst Market Capitalisation?
As of today, Health Catalyst (NASDAQ: HCAT) market cap is 106.70M USD.
What Is Health Catalyst's (HCAT) Earnings Per Share (TTM)?
The Health Catalyst EPS is currently -2.55 (Trailing Twelve Months).
When Is the Next Health Catalyst Earnings Date?
Health Catalyst's next earnings report will be released on 12/05/2026.
Is HCAT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Health Catalyst moving averages and other technical indicators, the daily buy/sell signal for HCAT stock is Strong Buy.
How Many Times Has Health Catalyst Stock Split?
Health Catalyst has split 0 times. (See the HCAT stock split history page for full effective split date and price information.)
How Many Employees Does Health Catalyst Have?
Health Catalyst has 1200 employees, based on their latest Companies House report.
What is the current trading status of Health Catalyst (NASDAQ: HCAT)?
As of 02/05/2026, Health Catalyst (HCAT) is trading at a share price of 1.45 USD, with a previous close of 1.25 USD. The stock has fluctuated within a day range of 1.27 USD to 1.48 USD, while its 52-week range spans from 0.96 USD to 5.06 USD.
What Is Health Catalyst (HCAT) Price Target According to Analysts?
The average 12-month price target for Health Catalyst is 1.96 USD, with a high estimate of 3 USD and a low estimate of 1 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +35.47% Upside potential.
What Is the HCAT Premarket Price?
HCAT's last pre-market stock price is 1.29 USD. The pre-market share volume is 1,230.00, and the stock has decreased by 0.04, or 3.20%.
What Is the HCAT After Hours Price?
HCAT's last after hours stock price is 1.53 USD, the stock has decreased by 0.08, or 5.52%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.